BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34313384)

  • 21. Genetic mutation screening in an italian cohort of nonsyndromic pheochromocytoma/paraganglioma patients.
    Castellano M; Mori L; Giacchè M; Agliozzo E; Tosini R; Panarotto A; Cappelli C; Mulatero P; Cumetti D; Veglio F; Agabiti-Rosei E
    Ann N Y Acad Sci; 2006 Aug; 1073():156-65. PubMed ID: 17102082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathology and genetics of phaeochromocytoma and paraganglioma.
    Turchini J; Cheung VKY; Tischler AS; De Krijger RR; Gill AJ
    Histopathology; 2018 Jan; 72(1):97-105. PubMed ID: 29239044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Somatic and occult germ-line mutations in SDHD, a mitochondrial complex II gene, in nonfamilial pheochromocytoma.
    Gimm O; Armanios M; Dziema H; Neumann HP; Eng C
    Cancer Res; 2000 Dec; 60(24):6822-5. PubMed ID: 11156372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Germline mutation landscape of multiple endocrine neoplasia type 1 using full gene next-generation sequencing.
    Carvalho RA; Urtremari B; Jorge AAL; Santana LS; Quedas EPS; Sekiya T; Longuini VC; Montenegro FLM; Lerario AM; Toledo SPA; Marx SJ; Toledo RA; Lourenço DM
    Eur J Endocrinol; 2018 Dec; 179(6):391-407. PubMed ID: 30324798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Aspects of SDHA-Related Pheochromocytoma and Paraganglioma: A Nationwide Study.
    van der Tuin K; Mensenkamp AR; Tops CMJ; Corssmit EPM; Dinjens WN; van de Horst-Schrivers ANA; Jansen JC; de Jong MM; Kunst HPM; Kusters B; Leter EM; Morreau H; van Nesselrooij BMP; Oldenburg RA; Spruijt L; Hes FJ; Timmers HJLM
    J Clin Endocrinol Metab; 2018 Feb; 103(2):438-445. PubMed ID: 29177515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma/Paraganglioma: Analysis of von Hippel-Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (TMEM127).
    Gupta S; Zhang J; Milosevic D; Mills JR; Grebe SK; Smith SC; Erickson LA
    Endocr Pathol; 2017 Sep; 28(3):253-268. PubMed ID: 28646318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Somatic mutations in H-RAS in sporadic pheochromocytoma and paraganglioma identified by exome sequencing.
    Crona J; Delgado Verdugo A; Maharjan R; Stålberg P; Granberg D; Hellman P; Björklund P
    J Clin Endocrinol Metab; 2013 Jul; 98(7):E1266-71. PubMed ID: 23640968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and genetic features of patients with multiple endocrine tumors who have neither family history nor MEN1 germline mutations.
    Sakurai A; Katai M; Yumita W; Minemura K; Hashizume K
    Endocrine; 2004 Feb; 23(1):45-9. PubMed ID: 15034196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The parathyroid/pituitary variant of multiple endocrine neoplasia type 1 usually has causes other than p27Kip1 mutations.
    Ozawa A; Agarwal SK; Mateo CM; Burns AL; Rice TS; Kennedy PA; Quigley CM; Simonds WF; Weinstein LS; Chandrasekharappa SC; Collins FS; Spiegel AM; Marx SJ
    J Clin Endocrinol Metab; 2007 May; 92(5):1948-51. PubMed ID: 17299066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pituitary adenoma with paraganglioma/pheochromocytoma (3PAs) and succinate dehydrogenase defects in humans and mice.
    Xekouki P; Szarek E; Bullova P; Giubellino A; Quezado M; Mastroyannis SA; Mastorakos P; Wassif CA; Raygada M; Rentia N; Dye L; Cougnoux A; Koziol D; Sierra Mde L; Lyssikatos C; Belyavskaya E; Malchoff C; Moline J; Eng C; Maher LJ; Pacak K; Lodish M; Stratakis CA
    J Clin Endocrinol Metab; 2015 May; 100(5):E710-9. PubMed ID: 25695889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Novel Germline c.1267T>A
    Gierlikowski W; Skwarek-Szewczyk A; Popow M
    Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33233395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
    Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A;
    Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Germline variants in familial pituitary tumour syndrome genes are common in young patients and families with additional endocrine tumours.
    De Sousa SMC; McCabe MJ; Wu K; Roscioli T; Gayevskiy V; Brook K; Rawlings L; Scott HS; Thompson TJ; Earls P; Gill AJ; Cowley MJ; Dinger ME; McCormack AI
    Eur J Endocrinol; 2017 May; 176(5):635-644. PubMed ID: 28220018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First report of bilateral pheochromocytoma in the clinical spectrum of HIF2A-related polycythemia-paraganglioma syndrome.
    Taïeb D; Yang C; Delenne B; Zhuang Z; Barlier A; Sebag F; Pacak K
    J Clin Endocrinol Metab; 2013 May; 98(5):E908-13. PubMed ID: 23539726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Germline mutations and genotype-phenotype correlation in Asian Indian patients with pheochromocytoma and paraganglioma.
    Pandit R; Khadilkar K; Sarathi V; Kasaliwal R; Goroshi M; Khare S; Nair S; Raghavan V; Dalvi A; Hira P; Fernandes G; Sathe P; Rojekar A; Malhotra G; Bakshi G; Prakash G; Bhansali A; Walia R; Kamalanathan S; Sahoo J; Desai A; Bhagwat N; Mappa P; Rajput R; Chandrashekhar SR; Shivane V; Menon P; Lila A; Bandgar T; Shah N
    Eur J Endocrinol; 2016 Oct; 175(4):311-23. PubMed ID: 27539324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spectrum of Germline RET variants identified by targeted sequencing and associated Multiple Endocrine Neoplasia type 2 susceptibility in China.
    Qi XP; Zhao JQ; Fang XD; Lian BJ; Li F; Wang HH; Cao ZL; Zheng WH; Cao J; Chen Y
    BMC Cancer; 2021 Apr; 21(1):369. PubMed ID: 33827484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenicity of DNA variants and double mutations in multiple endocrine neoplasia type 2 and von Hippel-Lindau syndrome.
    Erlic Z; Hoffmann MM; Sullivan M; Franke G; Peczkowska M; Harsch I; Schott M; Gabbert HE; Valimäki M; Preuss SF; Hasse-Lazar K; Waligorski D; Robledo M; Januszewicz A; Eng C; Neumann HP
    J Clin Endocrinol Metab; 2010 Jan; 95(1):308-13. PubMed ID: 19906784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a novel frameshift c.930delG MEN1 germline mutation (p.Glu273LysfsTer7) in a sporadic case of multiple endocrine neoplasia type 1: A case report.
    Naruse H; Umemura H; Nakayama T
    Mol Med Rep; 2020 Dec; 22(6):5423-5427. PubMed ID: 33173995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple endocrine neoplasia type 1 variant with frequent prolactinoma and rare gastrinoma.
    Hao W; Skarulis MC; Simonds WF; Weinstein LS; Agarwal SK; Mateo C; James-Newton L; Hobbs GR; Gibril F; Jensen RT; Marx SJ
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3776-84. PubMed ID: 15292304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of germline mutations in patients with pheochromocytoma or abdominal paraganglioma and sporadic presentation: a population-based study in Western Sweden.
    Muth A; Abel F; Jansson S; Nilsson O; Ahlman H; Wängberg B
    World J Surg; 2012 Jun; 36(6):1389-94. PubMed ID: 22270996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.